Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed.SummaryDifference1%

- Check11 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now renders a 403 Forbidden error, signaling that the study page is inaccessible; a Home link appears as part of the error page's navigation.SummaryDifference0.5%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.